Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds
EuroIntervention 2015;11:149-156 published online ahead of print December 2014. DOI: 10.4244/EIJY14M12_10
Jochen Wöhrle1, MD; Christoph Naber2, MD; Thomas Schmitz2, MD; Carsten Schwencke3, MD; Norbert Frey4, MD; Christian Butter5, MD; Johannes Brachmann6, MD; Maja Ingwersen3, DVM; Anna Drabik7, PhD; Sinisa Markovic1, MD; Detlef G. Mathey3*, MD
1. Department of Internal Medicine II, University of Ulm, Ulm, Germany; 2. Department of Cardiology and Angiology, Elisabeth-Krankenhaus Essen, Essen, Germany; 3. University Cardiovascular Center Hamburg, Hamburg, Germany; 4. Department of Cardiology and
Aims: Bioresorbable vascular scaffolds (BVS) have been available on the European market since November 2011. The ASSURE registry aims to investigate the safety and efficacy of the Absorb